Technical Analysis for ABT - Abbott Laboratories

Grade Last Price % Change Price Change
C 118.51 0.83% 0.97
ABT closed up 0.83 percent on Wednesday, May 5, 2021, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Down Down
Historical ABT trend table...

Date Alert Name Type % Chg
NR7 Range Contraction 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Inside Day Range Contraction 0.00%
Lower Bollinger Band Touch Weakness 0.00%
Oversold Stochastic Weakness 0.00%
MACD Bearish Centerline Cross Bearish 0.83%
Expansion Pivot Sell Setup Bearish Swing Setup 0.83%
Below Lower BB Weakness 0.83%
Down 3 Days in a Row Weakness 0.83%
Down 4 Days in a Row Weakness 0.83%
Older End-of-Day Signals for ABT ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 1% about 9 hours ago
Possible Inside Day about 10 hours ago
Possible NR7 about 10 hours ago
60 Minute Opening Range Breakout about 10 hours ago
1.5x Volume Pace about 14 hours ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Abbott Laboratories Description

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. Its Established Pharmaceutical Products segment offers branded generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, pain, fever, inflammation, hypothyroidism, gynecological disorders, intrahepatic cholestasis or depressive symptoms, physiological rhythm of the colon, dyslipidemia, and hypertension, as well as provides anti-infective and influenza vaccines. The company's Diagnostic Products segment provides diagnostic systems and tests, such as immunoassay and clinical chemistry systems; assays for screening and diagnosis for drugs of abuse, cancer, therapeutic drug monitoring, fertility, and physiological and infectious diseases; genomic-based tests; hematology systems and reagents; and diagnostic systems and tests for blood analysis, as well as instruments that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detects and measures infectious agents. Its Nutritional Products segment offers pediatric and adult nutritional products comprising various forms of prepared infant and follow-on formula. The company's Vascular Products segment provides coronary, endovascular, vessel closure, and structural heart devices for the treatment of vascular disease. Abbott Laboratories also offers blood glucose monitoring meters, test strips, and data management software and accessories for people with diabetes; and medical devices for the eye, including cataract surgery, LASIK surgery, contact lens care products, and dry eye products. The company primarily serves retailers, wholesalers, hospitals, health care facilities, laboratories, physicians' offices, and government agencies. The company was founded in 1888 and is headquartered in Abbott Park, Illinois.


Classification

Sector: Healthcare
Industry: Medical Devices
Keywords: Medicine Cancer Life Sciences Eye Pain Infectious Diseases Diabetes Pharmaceutical Products Inflammation Hypertension Hematology Influenza Symptoms Lab Testing Lipid Spas Thyroid Glucose Diagnostic Products Fertility Health Care Products Immunoassay Generic Pharmaceutical Influenza Vaccine Nutritional Products Blood Glucose Monitoring Cataract Fever Irritable Bowel Syndrome Contact Lens Dyslipidemia Influenza Vaccines Vascular Products Data Management Software Generic Pharmaceuticals Cataract Surgery Diagnostic Systems Lasik Vascular Disease Cholestasis Hypothyroidism Infectious Agents Intrahepatic Cholestasis Lens Care Products

Is ABT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 128.53
52 Week Low 86.16
Average Volume 4,210,840
200-Day Moving Average 111.79
50-Day Moving Average 120.17
20-Day Moving Average 121.54
10-Day Moving Average 120.92
Average True Range 2.09
ADX 17.02
+DI 17.28
-DI 28.27
Chandelier Exit (Long, 3 ATRs ) 119.15
Chandelier Exit (Short, 3 ATRs ) 122.69
Upper Bollinger Band 125.33
Lower Bollinger Band 117.76
Percent B (%b) 0.1
BandWidth 6.23
MACD Line -0.36
MACD Signal Line 0.24
MACD Histogram -0.5974
Fundamentals Value
Market Cap 210.04 Billion
Num Shares 1.77 Billion
EPS 1.89
Price-to-Earnings (P/E) Ratio 62.67
Price-to-Sales 5.95
Price-to-Book 6.07
PEG Ratio 3.38
Dividend 1.44
Dividend Yield 1.22%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 120.43
Resistance 3 (R3) 120.34 119.60 120.11
Resistance 2 (R2) 119.60 119.11 119.65 120.00
Resistance 1 (R1) 119.06 118.81 119.33 119.15 119.90
Pivot Point 118.32 118.32 118.46 118.37 118.32
Support 1 (S1) 117.78 117.83 118.05 117.87 117.12
Support 2 (S2) 117.04 117.53 117.09 117.02
Support 3 (S3) 116.50 117.04 116.91
Support 4 (S4) 116.59